Evaluating Adherence to Pharmacologic Treatment in Real-world Clinical Practice: A Comprehensive Analysis
Not Applicable
- Conditions
- Health Condition 1: M800- Age-related osteoporosis with current pathological fractureHealth Condition 2: M800- Age-related osteoporosis with current pathological fractureHealth Condition 3: E88- Other and unspecified metabolic disorders
- Registration Number
- CTRI/2024/01/061240
- Lead Sponsor
- Stavya Spine Hospital and Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
DEXA proven osteoporotic patients (T score less than-2.5)
Patients with history of fragility fractures
Patients consenting for participation in the study
Exclusion Criteria
Patients not fulfilling inclusion criteria.
Patients not consenting for participation.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Adherence rates to the drug regimens prescribed <br/ ><br>2.In case of defaulters, reasons for discontinuation of the drug <br/ ><br>Timepoint: patients will be followed up for a period of 2 years from the point of enrollment in the study.The patients will be scheduled for follow up at 3,6,12,18 and 24 months. <br/ ><br>
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI